Hall & Partners expands Japanese team

Obata has more than 10 years experience in health research, especially in the areas of diabetes, central nervous system (CNS), rheumatology, vaccines, respiratory diseases and medical devices.

Hall & Partners, global CEO of health, Abigail Stuart said: “Japan is a key market for our pharmaceutical clients and Yukiko will help service our clients in this market locally and globally.”

The Tokyo office opened earlier this year.